| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 512 | 2.327 | 782 | 1.418 | 1.064 | 3.538 | 1.944 | 2.325 | 11.290 | 11.843 |
| Total Income - EUR | 512 | 2.327 | 782 | 1.418 | 1.064 | 3.538 | 1.944 | 2.325 | 11.290 | 11.845 |
| Total Expenses - EUR | 454 | 3.531 | 5.750 | 1.520 | 892 | 7.904 | 3.720 | 2.535 | 10.852 | 13.310 |
| Gross Profit/Loss - EUR | 58 | -1.204 | -4.968 | -102 | 173 | -4.366 | -1.776 | -210 | 439 | -1.465 |
| Net Profit/Loss - EUR | 42 | -1.269 | -4.984 | -145 | 141 | -4.427 | -1.835 | -279 | 57 | -1.465 |
| Employees | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 1 |
Check the financial reports for the company - Farmateclin Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 208 | 206 | 202 | 198 | 230 | 261 | 0 | 0 | 0 | 119 |
| Current Assets | 30.215 | 28.671 | 27.624 | 26.098 | 25.071 | 21.813 | 18.515 | 16.890 | 19.006 | 39.664 |
| Inventories | 30.076 | 28.457 | 27.422 | 26.016 | 24.703 | 21.546 | 17.770 | 16.093 | 18.655 | 51.176 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19 |
| Cash | 139 | 214 | 202 | 82 | 368 | 268 | 745 | 797 | 351 | -11.532 |
| Shareholders Funds | 1.580 | 295 | -4.694 | -4.753 | -4.520 | -8.861 | -10.499 | -10.811 | -10.722 | -12.127 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 28.843 | 28.582 | 32.520 | 31.049 | 29.821 | 30.936 | 29.015 | 27.702 | 29.727 | 51.909 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmateclin Srl